Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Aneta Suder"'
Publikováno v:
Studia Medyczne, Vol 35, Iss 2, Pp 117-122 (2019)
Externí odkaz:
https://doaj.org/article/809e88aa2a30406a9894698edcade9a9
Autor:
Linda R Mileshkin, Kathleen N Moore, Elizabeth H Barnes, Val Gebski, Kailash Narayan, Madeleine T King, Nathan Bradshaw, Yeh Chen Lee, Katrina Diamante, Anthony W Fyles, William Small, David K Gaffney, Pearly Khaw, Susan Brooks, J Spencer Thompson, Warner K Huh, Cara A Mathews, Martin Buck, Aneta Suder, Thomas E Lad, Igor J Barani, Christine H Holschneider, Sylvia Van Dyk, Michael Quinn, Danny Rischin, Bradley J Monk, Martin R Stockler
Publikováno v:
The Lancet Oncology. 24:468-482
Autor:
Christopher J Sweeney, Andrew J Martin, Martin R Stockler, Stephen Begbie, Leanna Cheung, Kim N Chi, Simon Chowdhury, Mark Frydenberg, Lisa G Horvath, Anthony M Joshua, Nicola J Lawrence, Gavin Marx, John McCaffrey, Ray McDermott, Margaret McJannett, Scott A North, Francis Parnis, Wendy Parulekar, David W Pook, Martin Neil Reaume, Shahneen K Sandhu, Alvin Tan, Thean Hsiang Tan, Alastair Thomson, Francisco Vera-Badillo, Scott G Williams, Diana Winter, Sonia Yip, Alison Y Zhang, Robert R Zielinski, Ian D Davis, Ehtesham Abdi, Suzanne Allan, Patricia Bastick, Robert Blum, Karen Briscoe, Daniel Brungs, Sean Bydder, Bala Renuka Chittajallu, Michelle Cronk, Katharine Cuff, Anthony Dowling, Matthew George, Lisa Horvath, Elizabeth Hovey, Anthony Joshua, Narayan Karanth, Ganessan Kichenadasse, Laurence Krieger, Maitham Mathlum, Louise Nott, Zulfiquer Otty, David Pook, Shahneen Sandhu, Sanjeev Sewak, Amanda Stevanovic, Martin Stockler, Aneta Suder, Hsiang Tan, Javier Torres, Simon Troon, Craig Underhill, Andrew Weickhardt, Robert Zielinski, Tahir Abbas, Ghadeer Anan, Chris Booth, Holly Campbell, Kim Chi, Joseph Chin, Edmond Chouinard, Bryan Donnelly, Darrel Drachenberg, Amir Faghih, Antonio Finelli, Sebastien Hotte, Krista Noonan, Scott North, Mohammad Rassouli, Neil Reaume, Ricardo Rendon, Fred Saad, Evgeny Sadikov, Eric Vigneault, Pawel Zalewski, Patrick Morris, Miriam O'Connor, Paul Donnellan, Dearbhaile O'Donnell, Jim Edwards, Peter Fong, Simon Crabb, Omar Khan, Vincent Khoo, Graham Macdonald, Heather Payne, Angus Robinson, Jonathon Shamash, John Staffurth, Carys Thomas
Publikováno v:
The Lancet Oncology. 24:323-334
Autor:
Amy E McCart Reed, Therese McCurry, Georgina Hollway, Haidar Al-Saig, Vladimir Andelkovic, Katharine Cuff, Margaret Cummings, David Fairbairn, Po-ling Inglis, Gillian Jagger, Helene Johanson, Lauren Kalinowski, Olga Kondrashova, Lambros T. Koufariotis, Anna Kuchel, Rahul Ladwa, Chiyan Lau, Ben Lundie, Helen Mar Fan, Nicole McCarthy, Kathryn Middleton, Kowsalya Murugappan, Mark Nalder, Colleen Niland, Michelle K Nottage, Kenneth J O’Byrne, John V Pearson, Kate Roberts, Gorane Santamaria Hormaechea, Cameron Snell, Karin Steinke, Aneta Suder, Diana Tam, Euan Walpole, Natasha Woodward, Clement Wong, Ho Yi Wong, Wen Xu, Peter T Simpson, Nicola Waddell, Sunil R Lakhani
BackgroundThe cancer genomics field has embraced the advent of precision oncology, and vast volumes of data have been mined for biomarkers of drug actionability. While some cancers, such as lung cancer, have detailed panels of actionable genomic biom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26404667885c64935187c486cb1d20c0
https://doi.org/10.1101/2023.02.21.23286199
https://doi.org/10.1101/2023.02.21.23286199
Autor:
Linda R. Mileshkin, Kathleen N. Moore, Elizabeth H. Barnes, Val Gebski, Kailash Narayan, Madeleine T. King, Nathan Bradshaw, Yeh Chen Lee, Katrina Diamante, Anthony W. Fyles, William Small Jr., David K. Gaffney, Pearly Khaw, Susan Brooks, J. Spencer Thompson, Warner K. Huh, Cara A. Mathews, Martin Buck, Aneta Suder, Thomas E. Lad, Igor J. Barani, Christine H. Holschneider, Sylvia Van Dyk, Michael Quinn, Danny Rischin, Bradley J. Monk, Martin R. Stockler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0c9b2e00842a0e746ad28f7e4506dc7
https://doi.org/10.2139/ssrn.4335106
https://doi.org/10.2139/ssrn.4335106
Publikováno v:
Studia Medyczne, Vol 35, Iss 2, Pp 117-122 (2019)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7131667023f121f6904b139981de9b9c
https://ruj.uj.edu.pl/xmlui/handle/item/120595
https://ruj.uj.edu.pl/xmlui/handle/item/120595
Autor:
Ruth Plummer, Aneta Suder, N Cresti, J. Garcia Corbacho, I Kawabata, Duncan I. Jodrell, Linda Hogarth, James Spicer, S. Matsumoto, Eugene P. Frenkel, K Donaldson, J Posner, Debashis Sarker, Richard D. Baird
Publikováno v:
European Journal of Cancer. 51:137-145
Background S-222611 is a reversible inhibitor of EGFR, HER2 and HER4 with preclinical activity in models expressing these proteins. We have performed a Phase 1 study to determine safety, maximum tolerated dose (MTD), pharmacokinetic profile (PK) and
Publikováno v:
Expert Review of Anticancer Therapy. 13:1363-1371
Despite significant advances in the systemic treatment of metastatic renal cell carcinoma, long-term survival remains low. A potential way to improve outcomes in selected cases is the use of metastasectomy, which is part of the multimodal treatment o
Autor:
Henrik Møller, Aneta Suder, Aisyah Mohd Noor, Suzanne Vizor, Blair McLennan, Debashis Sarker, Sophie Papa, Sarah Hunter, James Spicer
Publikováno v:
Journal of Clinical Oncology. 31:224-230
Purpose Little is known about the influence of socioeconomic factors on patient access to cancer trials. Differences should be considered to ensure generalizability of trial results and equality of access. Methods Phase I trials unit referrals at our
Autor:
Debashis Sarker, Aneta Suder, Peter Stephens, Steen Knudsen, Elizabeth Ruth Plummer, Nicola Cresti, Sharon McGonigle, Yvette Drew, Barbara Ink, Marie Foegh, Divyanshu Dua
Publikováno v:
Journal of Clinical Oncology. 36:2505-2505
2505Background: A phase I study was done to establish the safety, MTD and anti-tumour efficacy of the novel PARP 1/2 and Tankyrase 1/2 inhibitor, 2X-121 (E7449). A novel tumor agnostic molecular bi...